GE HealthCarevs.Zimmer Biomet
GEHC vs ZBH · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
GE HealthCare is about 1.7× larger than Zimmer Biomet by market cap; GE HealthCare trades at the lower P/E (15.0 vs 21.5); year to date, Zimmer Biomet leads (−1.2% vs −21.7%).
Side by side
| GEHC | ZBH | |
|---|---|---|
| Market cap | $29.7B | $17.4B |
| Price | $65.74 | $89.14 |
| Today | +2.4% | +0.3% |
| Return YTD | −21.7% | −1.2% |
| Return 1Y | −14.5% | −9.6% |
| Since June 26, 2026 | −0.0% | −4.3% |
| P/E | 15.0 | 21.5 |
| P/S | 1.4 | 2.0 |
| P/B | 2.7 | 1.4 |
Data as of 2026-10-09 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
GE HealthCareGEHC
Imaging is the core: CT and MRI systems, plus ultrasound. Patient monitoring equipment and contrast agents round out a range sold worldwide.
Full GEHC profile →More GEHC & ZBH comparisons
Other head-to-heads in the Medtech & devices segment.
See where GEHC and ZBH sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →